This inventor holds 5 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Northwestern University, Beckman Research Institute, City of Hope. Active years: 1989-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Evanston, IL (US) (2015)
- Chicago, IL (US) (1989 - 2018)
Company Filing History:
4 out of 2,214 
1 out of 692 
Years Active: 1989-2025
Title: Innovations and Contributions of Steven T. Rosen
Introduction
Steven T. Rosen is a prominent inventor based in Chicago, IL (US), known for his significant contributions to the field of cancer treatment. With a total of 5 patents, he has made remarkable strides in developing innovative compounds and methods aimed at combating cancer and proliferative disorders.
Latest Patents
Among his latest patents, Rosen has developed substituted pyrrolo[2,3-d]pyrimidines for the treatment of cancer and proliferative disorders. These compounds have shown efficacy in inhibiting the growth of cancer cell lines, providing a promising avenue for cancer therapy. Another notable patent involves methods of treating cancer with GLUT inhibitors and oxidative phosphorylation inhibitors. This patent outlines methods for diagnosing and treating GLUT-dependent and OXPHOS-dependent cancers, offering a multifaceted approach to cancer treatment.
Career Highlights
Rosen is affiliated with Northwestern University, where he continues to advance research in cancer therapies. His work has garnered attention for its potential impact on the treatment landscape for various cancers, particularly those that have developed resistance to conventional therapies.
Collaborations
Rosen collaborates with esteemed colleagues, including Malathy Shanmugam and Karl A. Scheidt, enhancing the breadth and depth of his research endeavors.
Conclusion
Steven T. Rosen's innovative work in cancer treatment exemplifies the vital role of inventors in advancing medical science. His patents and research contributions are paving the way for new therapeutic strategies in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile